A rapid increase in serum NSE may be a useful indication of transformation from adenocarcinoma to SCLC in cases that are resistant to EGFR-TKI therapy.[15–17] In our case, the remarkable increase in serum levels of NSE highlighted the necessity for repeat biopsy and suggested SCLC transformation. This evidence concerns the gene ENO2 and adenocarcinoma.